2019 Global life sciences outlook focus and transform | Accelerating change in life sciences
Making a Breakthrough in Drug Discovery with AI
AI Drug Development Hit The News
Pfizer inks collaboration deal to use CytoReason’s cell-centered models of immune system:
Pfizer Taps Israeli Machine Learning Drug Discovery Company CytoReason (Hebrew)
CytoReason Signs Collaboration Agreement with Pfizer Inc. To Utilize CytoReason’s Machine Learning Model of the Immune System for Drug Discovery
From Mouse to man: New Machine Learning Model Reduces Number of ‘Wasted Experiments’
New CytoReason machine learning model turns mice into men (and women) to overcome the barrier of cross-species differences in drug development, published in Nature Methods
Found In Translation: a machine learning model for mouse-to-human inference
Five AI Healthcare Startups Bringing Us Closer to Cures
